Results 41 to 50 of about 17,150 (201)
The Turkish Journal of Gastroenterology, 2019 Background/Aims: When conservative methods fail, neostigmine is recommended in the pharmacological treatment of acute colonic pseudo-obstruction (ACPO).
Ömür İlban +4 more
doaj +1 more source
Using the post‐operative quality recovery scale to evaluate recovery with different neuromuscular blocking reversal agentsin the Portuguese population ‐ interim analysis results: 1AP3‐8 [PDF]
, 2013 Background and Goal of Study: Post-operative Quality Recovery Scale (PQRS), is the first scale evaluating several domains of postoperative recovery. The objectives of this study were to compare overal and physiologic, cognitive, and functional domains
Amorim, P. +5 more
core +1 more source
BMC Pharmacology and Toxicology, 2021 Background Surgical procedures cause perioperative immunosuppression and neuroendocrine stress, exerted by activation of the autonomic nervous system and the hypothalamic-pituitary-adrenal axis. The acetylcholinesterase inhibitor (ACHEI); neostigmine, is
Mennatallah A Gowayed +2 more
doaj +1 more source
Comparison of sugammadex and neostigmine–atropine on intraocular pressure and postoperative effects
Kaohsiung Journal of Medical Sciences, 2016 During surgery, changes in intraocular pressure (IOP) can be observed resulting from several factors, such as airway manipulations and drugs used. We aimed to investigate the effects of sugammadex and neostigmine on IOP, hemodynamic parameters, and ...
Sedat Hakimoğlu +9 more
doaj +1 more source
Error Traps in Pediatric Neuromuscular Block
Pediatric Anesthesia, EarlyView.ABSTRACT Background Neuromuscular blocking agents are essential for safe pediatric anesthesia but remain a frequent source of preventable morbidity when misused, inadequately monitored, or incompletely reversed. Children, particularly neonates and infants, are especially vulnerable to residual neuromuscular block due to developmental pharmacological ...
Gabriel Soares de Sousa +5 more
wiley +1 more source
Pediatric Anesthesia, EarlyView.ABSTRACT Background Neostigmine is widely used to reverse nondepolarizing neuromuscular blockade in children, but the optimal dose under total intravenous anesthesia is uncertain. Aims The primary aim was to compare the time to full neuromuscular recovery (TOF ratio of 1.0) following administration of neostigmine at doses of 0, 10, 20, and 30 μg/kg in ...
Antonio J. M. M. Neto +7 more
wiley +1 more source
BMC Anesthesiology, 2020 Background Sugammadex reduces postoperative complications. We sought to determine whether it could reduce the length of hospital stay, post-anesthetic recovery time, unplanned readmission, and charges for patients who underwent robot-assisted ...
Byung-Hun Min +3 more
doaj +1 more source
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients [PDF]
Korean Journal of Anesthesiology, 2013 BackgroundRapid and complete reversal of neuromuscular blockade (NMB) is desirable at the end of surgery. Sugammadex reverses rocuronium-induced NMB by encapsulation.
Tiffany Woo +8 more
doaj +1 more source
Guidelines for Essential Trauma Care: Second Edition (2026)
World Journal of Surgery, EarlyView.Injury is a major cause of death and disability globally, with the highest burden in low‐ and middle‐income countries (LMICs). Strengthening the organization and planning for trauma care (care of the injured) can improve care and lower mortality. In 2004, the International Association for Trauma Surgery and Intensive Care (IATSIC) and the World Health ...
Charles Mock +41 more
wiley +1 more source
BMC Anesthesiology, 2010 Background Acetylcholinesterase inhibitors cannot rapidly reverse profound neuromuscular block. Sugammadex, a selective relaxant binding agent, reverses the effects of rocuronium and vecuronium by encapsulation.
Lemmens Hendrikus JM +4 more
doaj +1 more source